Hidefumi Hiramatsu

18PUBLICATIONS
128CO-AUTHORS
Child and adolescent developmentCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAdolescent healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

|Jan 06, 2026
Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Katsutsugu Umeda, Satoshi Saida, Hirokazu Kobushi

|Jul 30, 2025
Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection.

Ryo Akazawa, Takashi Mikami, Masaki Yamada

|Dec 21, 2023
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.

Hirohito Kubota, Hiroo Ueno, Keiji Tasaka

|May 08, 2023
Current status of CAR-T cell therapy for pediatric hematologic malignancies.

Hidefumi Hiramatsu

|Dec 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.

Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani

Pageof 3

Frequent Collaborators

8 joint publications

Katsutsugu Umeda

7 joint publications

Hirohito Kubota

7 joint publications

Itaru Kato

6 joint publications

Junko Takita